BridgeMD
New treatment option for Hematopoietic and Lymphatic System Neoplasm
Official title CREATE: Art for Children With Cancer
ClinicalTrials.gov ID: NCT06342453
What this study is testing
- What it's testing
- This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of complementary health interventions which have been associated with improved quality of life and reduced symptom burden among children with cancer.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 13
You may be able to join if
- Aged 8 to 13 years of age
- Have been diagnosed with cancer of any type in the prior 12 months
- Be English literate (we will amend this criterium when the study surveys are validated in Spanish). Parent/caregiver of child participant may be...
- Physically and cognitively able to participate in creative arts
- Expected to receive enough treatment at local site to participate in all four intervention sessions
You likely can't join if
- Not English literate
- Otherwise unable to complete study procedures
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 13 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.